Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501).

Saved in:
Bibliographic Details
Title: Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501).
Authors: Watanabe S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan., Sakai K; Department of Genome Biology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan., Matsumoto N; Department of Respiratory Medicine, Nishiniigata Chuo National Hospital, Niigata 951-8510, Japan., Koshio J; Department of Respiratory Medicine, Nagaoka Red Cross Hospital, Nagaoka 940-2085, Japan., Ishida A; Department of Respiratory Medicine, Nagaoka Red Cross Hospital, Nagaoka 940-2085, Japan., Abe T; Department of Respiratory Medicine, Niigata City General Hospital, Niigata 951-8510, Japan., Ishikawa D; Department of Respiratory Medicine, Niigata Prefectural Shibata Hospital, Niigata 951-8510, Japan.; Department of Respiratory Medicine, Niigata Prefectural Central Hospital, Joetsu 943-0892, Japan., Tanaka T; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.; Department of Respiratory Medicine, Niigata Prefectural Central Hospital, Joetsu 943-0892, Japan., Aoki A; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata 951-8510, Japan., Kajiwara T; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata 951-8510, Japan., Koyama K; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata 951-8510, Japan., Miura S; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata 951-8510, Japan., Goto Y; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan., Sekiya T; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan., Suzuki R; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan., Kushiro K; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan., Fujisaki T; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan., Yanagimura N; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan., Ohtsubo A; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan., Shoji S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan., Nozaki K; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan., Saida Y; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan., Yoshizawa H; Department of Respiratory Medicine, Niigata Medical Center, Niigata 951-8510, Japan., Nishio K; Department of Genome Biology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan., Kikuchi T; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Source: Cancers [Cancers (Basel)] 2022 Dec 29; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 29.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers15010204